<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Understanding The Genetics of Parkinson&#8217;s Disease: A Work In Progress</title>
	<atom:link href="http://spittoon.23andme.com/2009/03/19/understanding-the-genetics-of-parkinsons-disease-a-work-in-progress/feed/" rel="self" type="application/rss+xml" />
	<link>http://spittoon.23andme.com/2009/03/19/understanding-the-genetics-of-parkinsons-disease-a-work-in-progress/</link>
	<description>A receptacle for genetic knowledge.</description>
	<lastBuildDate>Sat, 13 Feb 2010 03:51:43 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9</generator>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<item>
		<title>By: ErinC</title>
		<link>http://spittoon.23andme.com/2009/03/19/understanding-the-genetics-of-parkinsons-disease-a-work-in-progress/comment-page-1/#comment-1850</link>
		<dc:creator>ErinC</dc:creator>
		<pubDate>Thu, 21 May 2009 16:55:25 +0000</pubDate>
		<guid isPermaLink="false">http://spittoon.23andme.com/?p=2984#comment-1850</guid>
		<description>For both the G2385R mutation (Parkinson&#039;s Disease: Preliminary Research) and the G2019S mutation (Parkinson&#039;s Disease Clinical Report) just one copy of the riskier version is enough to increase the risk of Parkinson&#039;s disease.  In fact for both of these mutations, the effects of one or two copies are pretty much the same.  This is an example of a dominant mutation.

Having one copy of the G2385R mutation would mean having the AG genotype at rs34778348.  Two copies would mean that your genotype is AA.  One copy of the G2019S mutation means having the AG genotype at rs34637584.  Two copies means a genotype of AA.

You may be interested to know that the G2019S LRRK2 mutation is found at higher than average rates in Norwegians.  Check out the Frontline special &quot;My Father, My Brother and Me&quot; (http://www.pbs.org/wgbh/pages/frontline/parkinsons) in which reporter Dave Iverson recounts his family&#039;s experience with Parkinson&#039;s. At one point a researcher tells him that scientists suspect that the LRRK2 mutation spread from North Africa to Norway through the Vikings, who are known to have lived in and around Carthage in about 1000 A.D., leading Iverson to wonder, “Did my own family’s Parkinson’s saga begin a thousand years ago, when some seafaring relative came calling in Carthage?”</description>
		<content:encoded><![CDATA[<p>For both the G2385R mutation (Parkinson&#8217;s Disease: Preliminary Research) and the G2019S mutation (Parkinson&#8217;s Disease Clinical Report) just one copy of the riskier version is enough to increase the risk of Parkinson&#8217;s disease.  In fact for both of these mutations, the effects of one or two copies are pretty much the same.  This is an example of a dominant mutation.</p>
<p>Having one copy of the G2385R mutation would mean having the AG genotype at rs34778348.  Two copies would mean that your genotype is AA.  One copy of the G2019S mutation means having the AG genotype at rs34637584.  Two copies means a genotype of AA.</p>
<p>You may be interested to know that the G2019S LRRK2 mutation is found at higher than average rates in Norwegians.  Check out the Frontline special &#8220;My Father, My Brother and Me&#8221; (<a href="http://www.pbs.org/wgbh/pages/frontline/parkinsons" rel="nofollow">http://www.pbs.org/wgbh/pages/frontline/parkinsons</a>) in which reporter Dave Iverson recounts his family&#8217;s experience with Parkinson&#8217;s. At one point a researcher tells him that scientists suspect that the LRRK2 mutation spread from North Africa to Norway through the Vikings, who are known to have lived in and around Carthage in about 1000 A.D., leading Iverson to wonder, “Did my own family’s Parkinson’s saga begin a thousand years ago, when some seafaring relative came calling in Carthage?”</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Leilani54</title>
		<link>http://spittoon.23andme.com/2009/03/19/understanding-the-genetics-of-parkinsons-disease-a-work-in-progress/comment-page-1/#comment-1846</link>
		<dc:creator>Leilani54</dc:creator>
		<pubDate>Wed, 20 May 2009 22:55:14 +0000</pubDate>
		<guid isPermaLink="false">http://spittoon.23andme.com/?p=2984#comment-1846</guid>
		<description>I am of caucasion/Hawaiiam/Chinese ancestry. I am 54 years old formally diganosed with Parkinson&#039;s in 2006. I have the marker or both G2385r and G2019s mutations of the LRRK2. Estimated age of onset was age 42. 

Although my odds on 23 and me were in the &quot;typical range&quot;, would having +markers in both put me at an increased risk due to genetics? My paternal grandmother ( hawaiian/chinese) and grandfather ( norwegian) . My grandmother and father both developed Parkinsons&#039; in their late 70&#039;s. They are both deceased.

Would being + at both markers account for an increased risk as opposed to just + at one marker ?   Much thanks...L</description>
		<content:encoded><![CDATA[<p>I am of caucasion/Hawaiiam/Chinese ancestry. I am 54 years old formally diganosed with Parkinson&#8217;s in 2006. I have the marker or both G2385r and G2019s mutations of the LRRK2. Estimated age of onset was age 42. </p>
<p>Although my odds on 23 and me were in the &#8220;typical range&#8221;, would having +markers in both put me at an increased risk due to genetics? My paternal grandmother ( hawaiian/chinese) and grandfather ( norwegian) . My grandmother and father both developed Parkinsons&#8217; in their late 70&#8217;s. They are both deceased.</p>
<p>Would being + at both markers account for an increased risk as opposed to just + at one marker ?   Much thanks&#8230;L</p>
]]></content:encoded>
	</item>
</channel>
</rss>
